Authors

• Y Loriot
• Vadim S. Koshkin (ORCID: https://orcid.org/0000-0003-2277-8668)
• Daisy Lin
• G. Klauss
• J Z Guo
• Bradley McGregor
• Arnab Basu
• Alexandra Drakaki (ORCID: https://orcid.org/0000-0001-8865-3548)
• Parminder Singh
• Eiji Kikuchi (ORCID: https://orcid.org/0000-0002-1624-6676)
• Mark Fleming
• Matthew D. Galsky (ORCID: https://orcid.org/0000-0001-7655-9378)
• Chelsea Liu
• Benjamin Garmezy (ORCID: https://orcid.org/0000-0003-2790-6235)
• Thomas Powles (ORCID: https://orcid.org/0000-0001-7760-4724)
• Srikala S. Sridhar (ORCID: https://orcid.org/0000-0002-6994-1285)
• Andrea B. Apolo (ORCID: https://orcid.org/0000-0001-9409-1836)
• Jens Bedke (ORCID: https://orcid.org/0000-0003-2778-3108)

Institutions

• St. Marianna University School of Medicine (JP)
• Queen Mary University of London (GB)
• Sarah Cannon Research Institute (GB)
• Daiichi Sankyo (Germany) (DE)
• Peking University (CN)
• UCLA Health (US)
• Signature Healthcare Brockton Hospital (US)
• Cancer Institute (WIA) (IN)
• Institut Gustave Roussy (FR)
• WinnMed (US)
• Princess Margaret Cancer Centre (CA)
• Peking University Cancer Hospital (CN)
• May Institute (US)
• Mayo Clinic Hospital (US)
• Dana-Farber/Harvard Cancer Center (US)
• Daiichi-Sankyo (South Korea) (KR)
• UCSF Helen Diller Family Comprehensive Cancer Center (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Future Oncology

Published

2026-05-16

DOI

https://doi.org/10.1080/14796694.2026.2663956

Primary Topic

Bladder and Urothelial Cancer Treatments

Type

article

Field-Weighted Citation Impact

0.00